-
Factors Associated With Positive Cost-Effectiveness Judgments in HIRA Drug Reimbursement Decisions: An 8-year Retrospective Review
Sep 9, 2025, 16:22 PM -
Clinically Informed, Cost-Sensitive Machine Learning for Predicting Hospital-Acquired Pressure Injuries: A Practical Approach Using Routinely Collected Data
Sep 9, 2025, 16:22 PM -
Long-Term Impact of Emicizumab in Hemophilia A (HA): Analysis by Inhibitor Status in Three Latin American (LATAM) Countries
Sep 9, 2025, 16:22 PM -
Clinical Benefit vs. Reimbursement Decisions: Examining Misalignments Between ESMO-MCBS and HTA Outcomes in Oncology
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review of Economic Evaluation Studies for Schizophrenia
Sep 9, 2025, 16:22 PM -
A Real-World Retrospective Cohort Study Characterizing Healthcare Resource Utilization and Costs Among Patients With MMN in the United States
Sep 9, 2025, 16:22 PM -
Societal Value of Intravitreal Injections for Retinal Vascular Diseases in the National Reimbursement Drug List in China
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Ocrelizumab for Treating Relapsing Multiple Sclerosis in Austria
Sep 9, 2025, 16:22 PM -
The Impact of Socioeconomic and Clinical Factors on Mental Healthcare Expenditure: Enabling Quality Managed Care Decisions
Sep 9, 2025, 16:22 PM -
A Comparison of Treatment Costs for CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative HR+/HER2-: Early Breast Cancer (EBC) in Sweden
Sep 9, 2025, 16:22 PM -
Comparative Cost-Effectiveness Analysis of Isavuconazole vs. Liposomal Amphotericin B for the Treatment of Invasive Mucormycosis in Algerian Hospital Setting
Sep 9, 2025, 16:22 PM -
Balancing Fit and Accuracy: Evaluating Survival Model Projections With Immature Data in Health Technology Assessments
Sep 9, 2025, 16:22 PM -
A Review of Utility Data Used in Health Technology Assessments From the Perspective of a Health Technology Assessment Body
Sep 9, 2025, 16:22 PM -
Psychometric Validation Of The North Star Assessment For Limb-Girdle Type Muscular Dystrophies (NSAD) In Limb-Girdle Muscular Dystrophy Sarcoglycanopathies (LGMD 2C/2D/2E) Using Baseline JOURNEY Data...
Sep 9, 2025, 16:22 PM -
Predictive Algorithms in HTA: What Factors Influence Decision Making in NICE, SMC, and NCPE?
Sep 9, 2025, 16:22 PM -
Mental Health Benefits of Exercise Variation: Evidence From the 2024 5EU National Health and Wellness Survey
Sep 9, 2025, 16:22 PM -
Bridging the Survival Extrapolation Gap in Health Economic Models: A Case Study on Spline-Based Survival Analysis Using ML-NMR to Address Complex Hazard Function
Sep 9, 2025, 16:22 PM -
Bridging the Regulatory-Payer Evidence Gap: A Case Study With Six Minute Walk Distance and Mortality
Sep 9, 2025, 16:22 PM -
Micro-Costing Analysis of the Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis and Its Comorbidities in Saudi Arabia
Sep 9, 2025, 16:22 PM -
The Incidence and Economic Impact of Major Adverse Events Associated With Intravascular Temperature Management: A Systematic Review, Analysis, and Model
Sep 9, 2025, 16:22 PM
